NO905444L - Fremgangsmaate til fremstilling av oksazolderivater. - Google Patents

Fremgangsmaate til fremstilling av oksazolderivater.

Info

Publication number
NO905444L
NO905444L NO90905444A NO905444A NO905444L NO 905444 L NO905444 L NO 905444L NO 90905444 A NO90905444 A NO 90905444A NO 905444 A NO905444 A NO 905444A NO 905444 L NO905444 L NO 905444L
Authority
NO
Norway
Prior art keywords
oksazol
derivatives
procedure
preparation
oksazol derivatives
Prior art date
Application number
NO90905444A
Other languages
English (en)
Other versions
NO905444D0 (no
Inventor
Nicholas Meanwell
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO905444D0 publication Critical patent/NO905444D0/no
Publication of NO905444L publication Critical patent/NO905444L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90905444A 1989-12-20 1990-12-18 Fremgangsmaate til fremstilling av oksazolderivater. NO905444L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45354889A 1989-12-20 1989-12-20
US58002190A 1990-09-10 1990-09-10

Publications (2)

Publication Number Publication Date
NO905444D0 NO905444D0 (no) 1990-12-18
NO905444L true NO905444L (no) 1991-06-21

Family

ID=27037150

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90905444A NO905444L (no) 1989-12-20 1990-12-18 Fremgangsmaate til fremstilling av oksazolderivater.

Country Status (12)

Country Link
EP (1) EP0434034A1 (no)
JP (1) JPH04217966A (no)
KR (1) KR910011810A (no)
CN (4) CN1028173C (no)
CA (1) CA2032674A1 (no)
FI (1) FI906213A (no)
HU (2) HU206100B (no)
IL (1) IL96747A0 (no)
NO (1) NO905444L (no)
NZ (1) NZ236474A (no)
PT (1) PT96276A (no)
YU (1) YU240990A (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2179399A1 (en) * 1993-12-20 1995-06-29 Kiyoshi Taniguchi 4,5-diaryloxazole derivatives
TW401408B (en) * 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
US6506757B1 (en) * 1998-03-10 2003-01-14 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
PE20060362A1 (es) * 2004-05-24 2006-05-15 Irm Llc Compuestos de oxazol como moduladores de ppar
JP2009514974A (ja) * 2005-11-07 2009-04-09 アイアールエム・リミテッド・ライアビリティ・カンパニー Pparモジュレーターとしての化合物および組成物
US9181186B2 (en) 2012-02-13 2015-11-10 Takeda Pharmaceutical Company Limited Aromatic ring compound
JP6095580B2 (ja) 2012-02-13 2017-03-15 武田薬品工業株式会社 芳香環化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
US3895115A (en) * 1974-03-01 1975-07-15 Serono Ist Farm Method of inhibiting platelet aggregation
GB1507032A (en) * 1974-08-06 1978-04-12 Serono Lab 2-thiol-4,5-diphenyloxazole s-derivatives

Also Published As

Publication number Publication date
CN1028173C (zh) 1995-04-12
CN1052667A (zh) 1991-07-03
CN1101041A (zh) 1995-04-05
YU240990A (sh) 1992-12-21
IL96747A0 (en) 1991-09-16
FI906213A (fi) 1991-06-21
HU9201706D0 (en) 1992-08-28
CA2032674A1 (en) 1991-06-21
CN1101042A (zh) 1995-04-05
NO905444D0 (no) 1990-12-18
PT96276A (pt) 1991-09-30
FI906213A0 (fi) 1990-12-17
NZ236474A (en) 1993-07-27
HU908361D0 (en) 1991-07-29
EP0434034A1 (en) 1991-06-26
HU206100B (en) 1992-08-28
JPH04217966A (ja) 1992-08-07
HUT59116A (en) 1992-04-28
KR910011810A (ko) 1991-08-07
CN1101043A (zh) 1995-04-05

Similar Documents

Publication Publication Date Title
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO892936D0 (no) Fremgangsmaate for fremstilling av furanderivater.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903275D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905444L (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO891588D0 (no) Fremgangsmaate for fremstilling av fosfonoalkylpurinderivater.
NO901690L (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO883145L (no) Fremgangsmaate til fremstilling av tienoimidazol-derivater.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO894707L (no) Fremgangsmaate for fremstilling av benzoksazinderivater.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO892813L (no) Fremgangsmaate til fremstilling av l-alanyl-l-prolin-derivater.
NO904588D0 (no) Fremgangsmaate til fremstilling av diazinylpiperidin-derivater
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO904362D0 (no) Fremgangsmaate for fremstilling av kromanderivater.